
James Del Rosso, DO, Celebrates a Quarter Century of Dermatology Innovation in Las Vegas
Key Takeaways
- The Fall Clinical Dermatology Conference emphasizes practical education, focusing on evidence-based practice, innovation, and therapeutic pearls for immediate clinical application.
- Topics include inflammatory skin diseases, acne and rosacea management, emerging biologics, and procedural dermatology, with a strong emphasis on patient-centered care.
Del Rosso recounts the meeting’s evolution and its consistent mission to bridge science and practice.
As the
“The first Fall Clinical dermatology meeting was held 25 years ago right here in Las Vegas,” Del Rosso recalled. “We started small, and it has grown into one of the most well-respected and well-attended dermatology meetings in the country.”
This year’s sessions continue to emphasize evidence-based practice, innovation, and therapeutic pearls. Topics span inflammatory skin diseases, acne and rosacea management, emerging biologics, and procedural dermatology. According to Del Rosso, the strength of Fall Clinical lies in its blend of scientific rigor and real-world practicality.
“Attendees don’t just hear the data,” he said. “They learn how to incorporate it into clinical decisions the next time they’re in the office. That’s what has always made this meeting special.”
In addition to updates on topical and systemic therapies, the 2025 meeting places a strong emphasis on patient-centered care and the evolving role of dermatology providers in multidisciplinary medicine. Educational sessions also highlight new data on combination therapies and the use of technology in diagnosis and treatment monitoring.
Del Rosso emphasized the importance of collaboration and mentorship within the dermatologic community. “We have seasoned experts and new clinicians all in the same room,” he said. “That exchange of ideas keeps the specialty vibrant and ensures we’re always moving forward.”
As the meeting continues to expand, Fall Clinical remains committed to fostering education grounded in clinical reality. For Del Rosso, that mission has not changed in 25 years. “Our goal is to translate science into better patient outcomes,” he said. “That’s what keeps us coming back every year.”
Read more insights and clinical commentary from James Del Rosso, DO,
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.



















